Department of Natural Science and Biomedicine, University College of Health Sciences, Jönköping, Sweden.
Anticancer Res. 2013 Aug;33(8):3247-50.
It has been widely reported that matrix metalloproteinases (MMPs) have fundamental roles in pathological processes in cancer through degradation of basal membranes and extracellular matrix. For MMP12 and MMP13, a functional single nucleotide polymorphism (SNP) has been detected -82A →G (rs2276109) and -77A →G (rs2252070), respectively. These SNPs are suggested to have an influence on different diseases. The present study evaluated the association between these SNPs in patients with colorectal cancer (CRC) patients and healthy controls.
Using the TaqMan system, these SNPs were screened in 385 patients with CRC and 619 controls.
No significant difference in genotype distribution or in allelic frequencies was found between the two groups. However, we showed that the AA MMP-12 genotype is connected with a higher risk of disseminated CRC (Odds Ratio=1.77; 95% Confidence Interval=1.11-2.81, p=0.018).
The results of this study suggest that the -82A →G (rs2276109) polymorphism of the MMP12 gene reflects clinical outcome of patients with CRC.
已有大量报道表明,基质金属蛋白酶(MMPs)通过降解基底膜和细胞外基质,在癌症的病理过程中发挥着重要作用。对于 MMP12 和 MMP13,分别检测到一个功能性单核苷酸多态性(SNP)-82A →G(rs2276109)和-77A →G(rs2252070)。这些 SNP 被认为对不同的疾病有影响。本研究评估了这些 SNP 在结直肠癌(CRC)患者和健康对照组中的相关性。
使用 TaqMan 系统,在 385 例 CRC 患者和 619 例对照中筛选这些 SNP。
两组间基因型分布或等位基因频率无显著差异。然而,我们表明,MMP-12 基因的 AA 基因型与播散性 CRC 的风险增加相关(优势比=1.77;95%置信区间=1.11-2.81,p=0.018)。
本研究结果表明,MMP12 基因的-82A →G(rs2276109)多态性反映了结直肠癌患者的临床结局。